Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXaar Regulatory News (XAR)

Share Price Information for Xaar (XAR)

Share Price is delayed by 15 minutes
Get Live Data
138.00    -7.00 (-4.83%)
Bid:
138.00
Ask:
144.50
Spread: 6.50 (4.71%)
Market Cap: £108.29m
XAR Live PriceLast checked at - London Stock Exchange

Intraday Xaar Share Chart

Interim Management Statement

19 Apr 2010 07:00

RNS Number : 3236K
Xaar PLC
19 April 2010
 



 

 

 

FOR IMMEDIATE RELEASE

19 April 2010

 

 

 

Xaar plc

 

 

INTERIM MANAGEMENT STATEMENT

 

 

Xaar plc ("Xaar" or "the Group"), the inkjet printing technology group headquartered in Cambridge, is providing an Interim Management Statement covering trading from 1 January 2010 to 31 March 2010.

 

Trading and margins for the first quarter of the year were in line with the Board's expectations. Sales of Platform 1 ("P1") products have shown more stability than seen in recent periods and the increased demand for Platform 3 ("P3") products, first reported for the fourth quarter of last year, has continued. During Q1 2010, P3 demand continued to grow; the company is investing to increase output from the Huntingdon plant by mid-year.

 

The increase in P3 sales continues to be driven by volume sales into the industrial and packaging markets. We continue to work with our customers in these and other end markets to deliver levels of performance to allow them to move their printing machinery products to volume launch. We are still incurring some additional costs associated with new product introductions; however these are expected to reduce later this year as previously stated.

 

The consolidation of the Group's manufacturing facilities into a single plant in Huntingdon, England continues to progress according to schedule with the costs and benefits of the project remaining in line with the original plan.

 

The Group's balance sheet is strong with net cash at 31 March 2010 of £9.2m (31 December 2009: £11.1m).

 

The Board is encouraged by the rate of adoption of the Group's P3 products in new markets and remains satisfied with the relative stability of P1 sales in Xaar's traditional markets. The Board is now looking forward to volume sales of both P3 and new P1 products across a wider range of customers and end markets together with the reduction of new product support costs.

 

 

Ends

 

 

 

 

CONTACTS

 

Xaar plc:

01223-423663

Ian Dinwoodie, Chief Executive

www.xaar.com

Andrew Taylor, Finance Director

Singer Capital Markets Limited:

020-3205-7500

Shaun Dobson

Bankside Consultants:

Steve Liebmann or Andy Harris

020-7367-8883 / 07802-888159

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSBBGDSBUBBGGL
Date   Source Headline
2nd Jan 20182:52 pmRNSTotal Voting Rights
14th Dec 201711:11 amRNSAgreement
1st Dec 20171:55 pmRNSTotal Voting Rights
21st Nov 20178:56 amRNSNOTIFICATION OF MAJOR HOLDINGS
20th Nov 20177:00 amRNSTrading Statement
15th Nov 20179:20 amRNSXaar strengthens 2020 vision with two developments
1st Nov 201710:04 amRNSTotal Voting Rights
2nd Oct 20172:37 pmRNSTotal Voting Rights
8th Sep 201711:34 amRNSDirector/PDMR Shareholding
6th Sep 20172:43 pmRNS2017 Interim Results
6th Sep 20177:00 amRNS2017 Interim Results
1st Sep 201712:21 pmRNSTotal Voting Rights
17th Aug 201711:55 amRNSNOTIFICATION OF MAJOR HOLDINGS
9th Aug 20177:00 amRNSDirector change
1st Aug 20172:26 pmRNSTotal Voting Rights
12th Jul 20177:00 amRNSTrading Statement
4th Jul 20177:00 amRNSNotice of Scheduled Trading Statement
3rd Jul 20177:00 amRNSTotal Voting Rights
30th Jun 20179:36 amRNSBlock listing Interim Review
1st Jun 201711:33 amRNSTotal Voting Rights
18th May 201711:10 amRNSREPLACEMENT: Grant of Options
18th May 20178:56 amRNSGrant of Options
16th May 20171:24 pmRNSResult of AGM
2nd May 20171:13 pmRNSTotal Voting Rights
2nd May 20177:00 amRNSBoard Appointment
26th Apr 201710:05 amRNSNotice of 2017 AGM
18th Apr 20177:00 amRNSDirector/PDMR Shareholding - SIP Purchase
11th Apr 20179:35 amRNSDirector/PDMR Shareholding
11th Apr 20179:19 amRNSDirector/PDMR Shareholding
6th Apr 20174:19 pmRNSNOTIFICATION OF MAJOR INTEREST IN SHARES
5th Apr 201712:34 pmRNSTotal Voting Rights - Replacement
3rd Apr 20172:08 pmRNSTotal Voting Rights
3rd Apr 20179:43 amRNSWORLD LEADING 3D CENTRE FORMALLY OPENED
29th Mar 20171:11 pmRNSConfirmation of Board Changes
28th Mar 20173:22 pmRNSDirector/PDMR Shareholding
24th Mar 20172:42 pmRNSNotification of Major Interest in Shares
22nd Mar 20177:00 amRNSFinal Results
8th Mar 20173:11 pmRNSNotice of Scheduled Results
1st Mar 20174:38 pmRNSTotal Voting Rights
1st Feb 20175:42 pmRNSTotal Voting Rights
24th Jan 20177:00 amRNSAppointment of Chief Financial Officer
11th Jan 20177:00 amRNSXerox partnership agreement
3rd Jan 20174:23 pmRNSBlock listing Six Monthly Return
3rd Jan 20174:20 pmRNSTotal Voting Rights
15th Dec 20167:00 amRNSScheduled Trading Statement
15th Dec 20167:00 amRNSInvestment in 3D Printing
12th Dec 20167:00 amRNSNotice of Scheduled Trading Statement
1st Dec 20161:52 pmRNSTotal Voting Rights
1st Nov 20163:48 pmRNSTotal Voting Rights
21st Oct 20167:00 amRNSBoard change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.